Franklin Resources
PTGX icon

Franklin Resources’s Protagonist Therapeutics PTGX Stock Holding History

Franklin Resources’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.7M Buy
520,032
+382,161
+277% +$39.9M 0.01% 598
2026
Q1 		$14.5M Buy
137,871
+61,429
+80% +$5.44M ﹤0.01% 1095
2025
Q4 		$6.68M Sell
76,442
-6,476
-8% -$530K ﹤0.01% 1289
2025
Q3 		$5.51M Buy
82,918
+339
+0.4% +$19.3K ﹤0.01% 1386
2025
Q2 		$4.56M Buy
82,579
+3,535
+4% +$170K ﹤0.01% 1395
2025
Q1 		$3.82M Sell
79,044
-9,826
-11% -$412K ﹤0.01% 1441
2024
Q4 		$3.43M Buy
88,870
+7,279
+9% +$317K ﹤0.01% 1519
2024
Q3 		$3.78M Buy
81,591
+45,674
+127% +$1.85M ﹤0.01% 1477
2024
Q2 		$1.24M Buy
35,917
+4,073
+13% +$119K ﹤0.01% 1850
2024
Q1 		$921K Buy
+31,844
New +$866K ﹤0.01% 1988
2023
Q4 		– Sell
-11,853
Closed -$198K – 2700
2023
Q3 		$198K Sell
11,853
-29,231
-71% -$567K ﹤0.01% 2324
2023
Q2 		$1.13M Buy
41,084
+8,551
+26% +$214K ﹤0.01% 1596
2023
Q1 		$2.29M Buy
32,533
+17,785
+121% +$299K ﹤0.01% 1324
2022
Q4 		$161K Buy
+14,748
New +$124K ﹤0.01% 2047

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources's PTGX Position: Q2 2026 in Review

Franklin Resources increased its Protagonist Therapeutics (PTGX) stake by 277% in Q2 2026, buying an estimated $39.9M and bringing the position to 520,032 shares worth $63.7M. The position accounts for 0.01% of the portfolio, ranked #598.

Franklin Resources first reported a position in PTGX in Q4 2022 and has held it in 14 quarters since. 343 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Franklin Resources held 520,032 shares of Protagonist Therapeutics worth $63.7M as of Q2 2026.
  • Franklin Resources bought 382,161 Protagonist Therapeutics shares in Q2 2026, an estimated $39.9M.
  • Protagonist Therapeutics made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #598 holding.
  • Franklin Resources first reported a position in Protagonist Therapeutics in Q4 2022 and has held it in 14 quarters since.
  • 343 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.